BTK and B-cell chronic lymphocytic leukemia: For example in a study with 85 CLL (chronic lymphocytic leukemia) patients treated with the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib 7 patients developed Richter`s transformation, a more aggressive lymphoma form, during ibrutinib treatment [30].